Exogenous incorporation of neugc-rich mucin augments n-glycolyl sialic acid content and promotes malignant phenotype in mouse tumor cell lines

Journal of Experimental and Clinical Cancer Research

Volumn 28, Issue 1, 2009, Pages

  Gabri, Mariano R ^a   Otero, Laura L ^a   Gomez, Daniel E ^a   Alonso, Daniel F ^a  

^a UNIVERSIDAD NACIONAL DE QUILMES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

MUCIN; N GLYCOLOYLNEURAMINIC ACID; SIALIC ACID; GANGLIOSIDE GM3; MIXED FUNCTION OXIDASE; N ACETYLNEURAMINATE MONOOXYGENASE; N ACETYLNEURAMINIC ACID; N-ACETYLNEURAMINATE MONOOXYGENASE; N-GLYCOLYLNEURAMINIC ACID; NEURAMINIC ACID DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; MALIGNANT NEOPLASTIC DISEASE; MELANOMA B16; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SLOT BLOT HYBRIDIZATION; ANIMAL; EXPERIMENTAL MELANOMA; EXPERIMENTAL NEOPLASM; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; G(M3) GANGLIOSIDE; IMMUNOHISTOCHEMISTRY; MAMMARY NEOPLASMS, EXPERIMENTAL; MELANOMA, EXPERIMENTAL; MICE; MIXED FUNCTION OXYGENASES; MUCINS; N-ACETYLNEURAMINIC ACID; NEURAMINIC ACIDS; PHENOTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 74349111138     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-28-146     Document Type: Article

References (40)

1. Carbohydrate antigen sialyl Lewis a - its pathophysiological significance and induction mechanism in cancer progression. R Kannagi Chang Gung Med J, Chang Gung Med J 2007 30 189 209 17760270
2. Dissecting lipid raft facilitated cell signaling pathways in cancer. SK Patra, Biochim Biophys Acta 2008 1785 182 206 18166162
3. Achievements and challenges of sialic acid research. R Schauer, Glycoconj J 2000 17 485 99 10.1023/A:1011062223612 11421344
4. Human MUC4 mucin induces ultra-structural changes and tumorigenicity in pancreatic cancer cells. N Moniaux P Chaturvedi GC Varshney JL Meza JF Rodriguez-Sierra JP Aubert SK Batra, Br J Cancer 2007 97 345 357 10.1038/sj.bjc.6603868 17595659
5. CMP-N-acetylneuraminic acid hydroxylase: the first cytosolic Rieske iron-sulphur protein to be described in Eukarya. W Schlenzka L Shaw S Kelm CL Schmidt E Bill AX Trautwein F Lottspeich R Schauer, FEBS Lett 1996 385 197 200 10.1016/0014-5793(96)00384-5 8647250
6. Loss of N-glycolylneuraminic acid in humans: Mechanisms, consequences, and implications for hominid evolution. A Varki, Am J Phys Anthropol 2001 Suppl 33 54 69 10.1002/ajpa.10018 11786991
7. Characterization of the major and minor mucus glycoproteins from bovine submandibular gland. AP Corfield CD Corfield RW Veh SA Wagner JR Clamp R Schauer, Glycoconj J 1991 8 330 9 10.1007/BF00731345 1841675
8. Mechanism of uptake and incorporation of the non-human sialic acid N-glycolylneuraminic acid into human cells. M Bardor DH Nguyen S Diaz A Varki, J Biol Chem 2005 280 4228 37 10.1074/jbc.M412040200 15557321
9. Evidence for efficient uptake and incorporation of sialic acid by eukaryotic cells. C Oetke S Hinderlich R Brossmer W Reutter M Pawlita OT Keppler, Eur J Biochem 2001 268 4553 61 10.1046/j.1432-1327.2001.02379.x 11502217
10. Biological behavior of malignant melanoma cells correlated to their survival in vivo. IJ Fidler, Cancer Res 1975 35 218 24 1109790
11. Urokinase-type Plasminogen Activator Activity Released by Clonal Tumor Cell Population Isolated During the Growth of a Murine Mammary Adenocarcinoma. DF Alonso EF Farías ED Bal de Kier Joffé J Exp Clin Cancer Res 1994 13 211 216
12. A naturally occurring 46-amino acid deletion of cytidine monophospho-N-acetylneuraminic acid hydroxylase leads to a change in the intracellular distribution of the protein. S Koyama T Yamaji H Takematsu T Kawano Y Kozutsumi A Suzuki T Kawasaki, Glycoconj J 1996 13 353 8 10.1007/BF00731467 8781965
13. A mouse IgG1 monoclonal antibody specific for N-glycolyl GM3 ganglioside recognized breast and melanoma tumors. A Carr A Mullet Z Mazorra AM Vzquez M Alfonso C Mesa E Rengifo R Pérez LE Fernndez, Hybridoma 2000 19 241 7 10.1089/02724570050109639 10952412
14. Generation and characterization of an anti-idiotype monoclonal antibody related to GM3(NeuGc) ganglioside. M Rodríguez L Llanes A Pérez R Pérez AM Vzquez, Hybrid Hybridomics 2003 22 307 14 10.1089/ 153685903322538836 14678648
15. Structure and molecular interactions of a unique antitumor antibody specific for N-glycolyl GM3. U Krengel LL Olsson C Martínez A Talavera G Rojas E Mier J Angström E Moreno, J Biol Chem 2004 279 5597 603 10.1074/jbc.M311693200 14627696
16. Adhesion to the extracellular matrix regulates the coupling of the small GTPase Rac to its effector PAK. MA Del Pozo LS Price NB Alderson XD Ren MA Schwartz, EMBO J 2000 19 2008 14 10.1093/emboj/19.9.2008 10790367
17. The biosynthesis of N-glycoloylneuraminic acid occurs by hydroxylation of the CMP-glycoside of N-acetylneuraminic acid. L Shaw R Schauer, Biol Chem Hoppe Seyler 1988 369 477 86 3202954
18. The distribution of sialic acids in nature. L Warren, Comp Biochem Physiol 1963 10 153 71 10.1016/0010-406X(63)90238-X 14109742
19. N-glycolylneuraminic acid deficiency in mice: implications for human biology and evolution. M Hedlund P Tangvoranuntakul H Takematsu JM Long GD Housley Y Kozutsumi A Suzuki A Wynshaw-Boris AF Ryan RL Gallo N Varki A Varki, Mol Cell Biol 2007 27 4340 4346 10.1128/MCB.00379-07 17420276
20. Ganglioside expression in tissues of mice lacking beta2-microglobulin. A Markoti A Marusi J Tomac J Müthing, Clin Exp Immunol 2002 128 27 35 10.1046/j.1365-2249.2002.01802.x 11982587
21. The molecular basis for the absence of N-glycolylneuraminic acid in humans. A Irie S Koyama Y Kozutsumi T Kawasaki A Suzuki, J Biol Chem 1998 273 15866 71 10.1074/jbc.273.25.15866 9624188
22. Siglecs - the major subfamily of I-type lectins. A Varki T Angata, Glycobiology 2006 16 1R 27R 10.1093/glycob/cwj008 16014749
23. Siglecs and their roles in the immune system. PR Crocker JC Paulson A Varki, Nat Rev Immunol 2007 7 255 66 10.1038/nri2056 17380156
24. Sialic acid species as a determinant of the host range of influenza A viruses. Y Suzuki T Ito T Suzuki RE Holland Jr TM Chambers M Kiso H Ishida Y Kawaoka, J Virol 2000 74 11825 31 10.1128/JVI.74.24.11825-11831.2000 11090182
25. Evolution of human chimpanzee differences in malaria susceptibility: relationship to human genetic loss of N-glycolylneuraminic acid. MJ Martin JC Rayner P Gagneux JW Barnwell A Varki, Proc Natl Acad Sci USA 2005 102 12819 24 10.1073/pnas.0503819102 16126901
26. N-glycolyl GM1 ganglioside as a receptor for simian virus 40. MA Campanero-Rhodes A Smith W Chai S Sonnino L Mauri RA Childs Y Zhang H Ewers A Helenius A Imberty T Feizi, J Virol 2001 81 12846 58 10.1128/JVI.01311-07
27. Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins. A Varki, Nature 2007 446 1023 9 10.1038/nature05816 17460663
28. Glycosylation in bladder cancer. C Ohyama, Int J Clin Oncol 2008 13 308 13 10.1007/s10147-008-0809-8 18704630
29. Active specific immunotherapy of melanoma with a GM3 ganglioside-based vaccine: a report on safety and immunogenicity. MD Guthmann RJ Bitton AJ Carnero MR Gabri G Cinat L Koliren D Lewi LE Fernandez DF Alonso DE Gámez L Fainboim, J Immunother 2004 27 442 51 10.1097/00002371-200411000-00004 15534488
30. Silencing of GM3 synthase suppresses lung metastasis of murine breast cancer cells. Y Gu J Zhang W Mi J Yang F Han X Lu W Yu, Breast Cancer Res 2008 10 1 10.1186/bcr1841 18171481
31. Ganglioside biosynthetic gene expression in experimental mouse brain tumors. JA Ecsedy MG Manfredi HC Yohe TN Seyfried, Cancer Res 1997 57 1580 3 9108463
32. Influence of host cell infiltration on the glycolipid content of mouse brain tumors. TN Seyfried M el-Abbadi JA Ecsedy HW Bai HC Yohe, J Neurochem 1996 66 2026 33 8780032
33. Clinical evidences of GM3 (NeuGc) ganglioside expression in human breast cancer using the 14F7 monoclonal antibody labelled with (99 m)Tc. JP Oliva Z Valdés A Casacá G Pimentel J Gonzlez I Alvarez M Osorio M Velazco M Figueroa R Ortiz X Escobar M Orozco J Cruz S Franco M Díaz L Roque A Carr AM Vzquez C Mateos MC Rubio R Pérez LE Fernndez, Breast Cancer Res Treat 2006 96 115 21 10.1007/s10549-005-9064-0 16322892
34. N-Glycolylneuraminic acid in human tumors. YN Malykh R Schauer L Shaw, Biochimie 2001 83 623 34 10.1016/S0300-9084(01)01303-7 11522391
35. Detection and characterization of n-glycolylated gangliosides in wilms tumor by immunohistochemistry. AM Scursoni L Galluzzo S Camarero N Pozzo MR Gabri C Mateo de Acosta AM Vazquez DF Alonso MT G de Dvila, Pediatr Dev Pathol 2009 19435393
36. Hypoxic culture induces expression of sialin, a sialic acid transporter, and cancer-associated gangliosides containing non-human sialic acid on human cancer cells. J Yin A Hashimoto M Izawa K Miyazaki GY Chen H Takematsu Y Kozutsumi A Suzuki K Furuhata FL Cheng CH Lin C Sato K Kitajima R Kannagi, Cancer Res 2006 66 2937 45 10.1158/0008-5472.CAN-05-2615 16540641
37. Muc4/sialomucin complex, the intramembrane ErbB2 ligand, in cancer and epithelia: to protect and to survive. KL Carraway A Perez N Idris S Jepson M Arango M Komatsu B Haq SA Price-Schiavi J Zhang CA Carraway, Prog Nucleic Acid Res Mol Biol 2002 71 149 85 full-text 12102554
38. Heterogeneity of mucin gene expression in normal and neoplastic tissues. SB Ho GA Niehans C Lyftogt PS Yan DL Cherwitz ET Gum R Dahiya YS Kim, Cancer Res 1993 53 641 51 7678777
39. Ganglioside-based vaccines and anti-idiotype antibodies for active immunotherapy against cancer. LE Fernandez DF Alonso DE Gomez AM Vazquez, Expert Rev Vaccines 2003 2 817 823 10.1586/14760584.2.6.817 14711364
40. Progress and challenges in the vaccine-based treatment of head and neck cancers. A Venuti, J Exp Clin Cancer Res 2009 28 69 81 10.1186/1756-9966-28-69 19473517